Serum Institute of India and Novavax together are set to produce 100 crore units of the COVID-19 vaccine.

Novavax and Serum Institute of India are in partnership to produce, commercialize, and develop up to one billion vaccine doses for India.

Serum Institute of India(SII), on August 07, 2020, stated that it had entered a new partnership with international vaccine alliance Gavi and Bill & Melinda Gates Foundation. The agreement is to speed up manufacturing and deliver up to one billion doses of COVID-19 vaccines for India and other low and middle-income countries(LMICs). It excludes significant upper-middle and high-income countries, for which Novavax continues to hold rights. The reports state that Novavax company expects the agreement to support a minimum of one billion doses of NVX-CoV2373 for India and low- and middle-income countries. SII has set an affordable ceiling price of US $3 per dose.

Reference links

Novavax Inc. - IR Site

supports

Serum Institute of India Private Limited

supports

Have a question or correction?

Please tell us if you think this claim had been misjudged or requires correction by sending us evidence to support your error claim. We will revisit our evidence and verdict and do some additional research to double check if we can verify the new information

Fact Check of the Day

misleading

The Biden administration has shipped pallets of baby formula to migrant holding facilities despite a national shortage.